Drug Shortage Report for TEVA-RAMIPRIL

Last updated on 2018-01-04 History
Report ID 19981
Drug Identification Number 02247946
Brand name TEVA-RAMIPRIL
Common or Proper name RAMIPRIL
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) RAMIPRIL
Strength(s) 5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 500
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-08-20
Estimated end date 2017-11-30
Actual end date 2018-01-03
Shortage status Resolved
Updated date 2018-01-04
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2018-01-04 English Compare
v12 2018-01-03 French Compare
v11 2018-01-03 English Compare
v10 2017-10-10 French Compare
v9 2017-10-10 English Compare
v8 2017-10-10 English Compare
v7 2017-10-10 French Compare
v6 2017-10-10 English Compare
v5 2017-10-01 English Compare
v4 2017-09-19 French Compare
v3 2017-09-19 English Compare
v2 2017-08-21 French Compare
v1 2017-08-21 English Compare